Company: CWAN
Filing Date: 2025-03-31
Form Type: 425
Source: 0001193125-25-067656
Chunk: 3

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-31
Form: 425
Chunk 3
---
 SEC a Registration Statement on Form S-4 (the
“Registration Statement”) to register the shares of Clearwater’s common stock to be issued pursuant to the Mergers. The Registration Statement was declared effective by the SEC on March 12, 2025 and Enfusion and Clearwater filed
a Definitive Proxy Statement/Prospectus on March 20, 2025. The Definitive Proxy Statement/Prospectus was mailed, on or about March 20, 2025, to Enfusion shareholders of record as of March 20, 2025. Each of Clearwater and Enfusion may
also file other documents with the SEC regarding the Mergers. This Supplement is not a substitute for the Definitive Proxy Statement/Prospectus or any other document which Clearwater or Enfusion may file with the SEC in connection with the Mergers.
BEFORE MAKING ANY VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE
DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE MERGERS, THE RISKS RELATED THERETO, AND RELATED MATTERS. Investors and security holders will be able to
obtain free copies of the Definitive Proxy Statement/Prospectus, and other relevant documents filed by Clearwater and Enfusion with the SEC (if and when available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed
with the SEC by Clearwater, including the Definitive Proxy Statement/Prospectus are also available free of charge from Clearwater’s website at investors.clearwateranalytics.com/overview. Copies of documents filed with the SEC by Enfusion,
including the Definitive Proxy Statement/Prospectus are also available free of charge from Enfusion’s website at ir.enfusion.com.

Participants in the Solicitation

Clearwater, Enfusion and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in
respect of the Mergers. Information about Clearwater’s directors and executive officers is available in Clearwater’s Annual Report on Form 10-K for the year ended December 31, 2024